The Prognostic Value of Human Papilloma Virus in Nasopharyngeal Carcinoma
NCT04014738 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2019-07-10
Summary
It is well established that HPV infection has a casual and is a prognostic factor in several cancer types, including oropharynx. We wish to examine if HPV infection has a prognostic significance in nasopharyngeal carcinoma.
Conditions
- Nasopharyngeal Carcinoma
Sponsors & Collaborators
-
Rambam Health Care Campus
lead OTHER
Principal Investigators
-
Eran S Fridman, MD · Rambam Health Care Campus
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-07-20
- Primary Completion
- 2020-07-31
- Completion
- 2020-12-31
Countries
- Israel
Study Locations
More Related Trials
-
A Study of Reduced Radiation Therapy With Chemotherapy in People With HPV-Positive Throat Cancer
NCT06984861 ·Status: RECRUITING ·Phase: PHASE2
-
A Study of Reduced Radiation Therapy and Standard-of-Care Chemotherapy in People With HPV-Positive Throat Cancer
NCT05491512 ·Status: RECRUITING ·Phase: PHASE2
-
Exosome Testing as a Screening Modality for Human Papillomavirus-Positive Oropharyngeal Squamous Cell Carcinoma
NCT02147418 ·Status: COMPLETED
-
Durvalumab Before Surgery in Treating Patients With Oral Cavity or Oropharynx Cancer
NCT02827838 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Pharmacodynamic Study to Assess the Anti-proliferative Activity of the PARP Inhibitor Olaparib in Patients With HPV Positive and HPV Negative HNSCC
NCT02686008 ·Status: WITHDRAWN ·Phase: PHASE1
-
Patients with Human Papillomavirus-associated Head and Neck Cancer for the Discovery of Predictive Biomarkers to Guide Clinical Intervention
NCT06821243 ·Status: RECRUITING
-
Pyrimethamine as an Inhibitor of NRF2 in HPV-unrelated Locally Advanced Head and Neck Squamous Cell Carcinoma
NCT05678348 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
De-Escalation Protocol Of HPV Mediated Oropharyngeal Squamous Cell Carcinoma
NCT04638465 ·Status: ACTIVE_NOT_RECRUITING
-
De-intensification of Radiation and Chemotherapy for Low-Risk HPV-related Oropharyngeal SCC: Follow-up Study
NCT02281955 ·Status: COMPLETED ·Phase: PHASE2
-
HPV in Sinonasal Ca: Retrospective Analysis Association of Human Papilloma Virus (HPV) Serology and Behavioral Risk Factors
NCT04979000 ·Status: COMPLETED
-
Study of Chemotherapy Prior to Radiotherapy and Chemotherapy in Patients With HPV Associated Cancer of the Oral Cavity
NCT01525927 ·Status: TERMINATED ·Phase: PHASE2
-
Transoral Surgical Resection Followed by De-escalated Adjuvant IMRT in Resectable p16+ Locally Advanced Oropharynx Cancer
NCT05388773 ·Status: RECRUITING ·Phase: PHASE2
-
Transoral Surgery Followed By Low-Dose or Standard-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With HPV Positive Stage III-IVA Oropharyngeal Cancer
NCT01898494 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
De-escalated Radiation for Human Papillomavirus-Positive Squamous Cell Carcinoma of the Oropharynx
NCT05600842 ·Status: RECRUITING
-
HYHOPE: De-intensified Hypofractionated Radiation Therapy for HPV-associated Oropharynx Cancer
NCT04580446 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Human Papillomavirus Diagnosis on Relationships of Patients With Head and Neck Cancer
NCT04666428 ·Status: COMPLETED
-
Paclitaxel and Carboplatin Before Radiation Therapy With Paclitaxel in Treating HPV-Positive Patients With Stage III-IV Oropharynx, Hypopharynx, or Larynx Cancer
NCT02048020 ·Status: COMPLETED ·Phase: PHASE2
-
De-escalation of Adjuvant Radiation for Low-Risk HPV Oropharyngeal Cancers
NCT06554158 ·Status: RECRUITING ·Phase: NA
-
Using CircuLating Tumor DNA to Risk Adapt Post-Operative Therapy for HPV-associated Oropharyngeal Cancer
NCT06445114 ·Status: RECRUITING ·Phase: PHASE2
-
Trial of Individualized Adaptive RT in HPV-related High Risk Oropharynx Cancer
NCT06234748 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Docetaxel/Cisplatin/5-Fluorouracil (TPF) Human Papillomavirus (HPV) Squamous Cell Carcinoma Study
NCT01221753 ·Status: TERMINATED ·Phase: PHASE2
-
Response-Adaptive Treatment in Untreated Locoregional HPV-Negative Head and Neck Cancer
NCT07065630 ·Status: RECRUITING ·Phase: PHASE2
-
Swallowing Outcomes and Circulating Tumor DNA in Patients With HPV Related Oropharyngeal Cancer Treated With Transoral Surgery and Reduced Intensity Adjuvant Therapy
NCT04920344 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Feasibility and Tolerance of Nivolumab Neoadjuvant Immunotherapy in High Risk HPV Driven Oropharynx Cancer
NCT03838263 ·Status: COMPLETED ·Phase: PHASE2
-
RBD-HPV: Risk-Based De-Intensification for HPV+ HNSCC
NCT04849377 ·Status: WITHDRAWN ·Phase: PHASE2